Notice of Intent to issue a Sole Source Award for a GentleMACS Octo Dissociator with Heaters

The Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases intends to award a sole source firm fixed price purchase order to Miltenyi Biotec Inc for a GentleMACS Octo Dissociator with heating units. The system is capable of simultaneously processing eight biological samples in a fully closed, sterile system with integrated heating and validated programmable protocols. The contract action is for a commercial supply, and the government intends to solicit and negotiate with only one source under the authority of FAR 12.102(a). Some key points to consider are: • The GentleMACS Octo Dissociator with heating units is the only commercially available instrument capable of simultaneously processing eight biological samples in a fully closed, sterile system. • The system has a proprietary mechanical dissociation architecture, protected by active patents, which allows for reproducible, high-viability single-cell and nuclei preparations. • The system supports the required consumable formats (C Tubes and M Tubes) that maintain sterility and traceability. • The contract action is for a commercial supply, and the government intends to solicit and negotiate with only one source.